blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2135863

EP2135863 - Fluorescent pyrazine derivatives and methods of using the same in assessing renal function [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.07.2012
Database last updated on 14.09.2024
Most recent event   Tooltip27.07.2012Application deemed to be withdrawnpublished on 29.08.2012  [2012/35]
Applicant(s)For all designated states
Mallinckrodt LLC
675 McDonnell Boulevard
Hazelwood, MO 63042 / US
[2011/38]
Former [2009/52]For all designated states
MALLINCKRODT, INC.
675 McDonnell Boulevard
Hazelwood, MO 63042 / US
Inventor(s)01 / Rajagopalan, Raghavan
13031 Vinson Court Maryland Heights
Missouri 63043 / US
02 / Dorshow, Richard B.
11977 Neihaus Lane
St. Louis Missouri 63146 / US
03 / Neumann, William L.
212 W. Monroe
St. Louis Missouri 63122 / US
04 / Moore, Dennis A.
111 Barto
St Louis Missouri 63135 / US
 [2009/52]
Representative(s)Thurston, Joanna, et al
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[N/P]
Former [2009/52]Westwood, Joanna, et al
Withers & Rogers LLP Goldings House 2 Hays Lane
London SE1 2HW / GB
Application number, filing date09011710.222.12.2005
[2009/52]
Priority number, dateUS20040638611P23.12.2004         Original published format: US 638611 P
[2009/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2135863
Date:23.12.2009
Language:EN
[2009/52]
Search report(s)(Supplementary) European search report - dispatched on:EP06.11.2009
ClassificationIPC:C07D241/26
[2009/52]
CPC:
C07D241/28 (EP,US); A61K31/4965 (EP,US); A61K49/0004 (EP,US);
A61K49/0021 (EP,US); A61K49/0052 (EP,US); C07D241/20 (EP,US);
C07D241/26 (EP,US); C07D487/14 (US); B01J2219/1206 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/52]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:Fluoreszierende Pyrazin-Derivate und Verwendungsverfahren dafür bei der Überprüfung der Nierenfunktion[2009/52]
English:Fluorescent pyrazine derivatives and methods of using the same in assessing renal function[2009/52]
French:Dérivés de pyrazine fluorescents et leurs procédés d'utilisation dans l'évaluation de la fonction rénale[2009/52]
Examination procedure16.06.2010Amendment by applicant (claims and/or description)
16.06.2010Examination requested  [2010/30]
14.04.2011Despatch of a communication from the examining division (Time limit: M04)
09.08.2011Reply to a communication from the examining division
24.10.2011Communication of intention to grant the patent
06.03.2012Application deemed to be withdrawn, date of legal effect  [2012/35]
12.04.2012Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2012/35]
Parent application(s)   TooltipEP05855315.7  / EP1836175
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050855315) is  11.10.2007
Fees paidRenewal fee
28.09.2009Renewal fee patent year 03
28.09.2009Renewal fee patent year 04
28.12.2009Renewal fee patent year 05
27.12.2010Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.12.201107   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XD]  - TAYLOR, AT AL., "Pyrimidopteridines b< Oxidative Self-condensation of Aminopyrimidines", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (1955), vol. 77, pages 2243 - 2248, XP002551522 [XD] 1-9 * pages 2244, 2247;; compounds XII, XV *

DOI:   http://dx.doi.org/10.1021/ja01613a066
by applicantUS3814757
 US3948895
 US6440389
    - TAYLOR ET AL., JACS, (1955), vol. 77, pages 2243 - 2248
    - KIM ET AL., DYES AND PIGMENTS, (1998), vol. 39, pages 341 - 357
    - KIM ET AL., DYES AND PIGMENTS, (1999), vol. 41, pages 183 - 191
    - NALLY, J.V., "Acute renal failure in hospitalized patients", CLEVELAND CLINIC JOURNAL OF MEDICINE, (2002), vol. 69, no. 7, pages 569 - 574
    - C.A. RABITO; L.S.T. FANG; A.C. WALTMAN, "Renal function in patients at risk with contrast material-induced acute renal failure: Noninvasive real-time monitoring", RADIOLOGY, (1993), vol. 186, pages 851 - 854
    - N.L. TILNEY; J.M. LAZARUS., "Acute renal failure in surgical patients: Causes, clinical patterns, and care", SURGICAL CLINICS OF NORTH AMERICA, (1983), vol. 63, pages 357 - 377
    - B.E. VANZEE; W.E. HOY; J.R. JAENIKE., "Renal injury associated with intravenous pyelography in non-diabetic and diabetic patients", ANNALS OF INTERNAL MEDICINE, (1978), vol. 89, pages 51 - 54
    - S. LUNDQVIST ET AL., "Iohexol clearance for renal function measurement in gynecologic cancer patients", ACTA RADIOLOGICA, (1996), vol. 37, pages 582 - 586
    - P. GUESRY ET AL., "Measurement of glomerular filtration rate by fluorescent excitation of non-radioactive meglumine iothalamate", CLINICAL NEPHROLOGY, (1975), vol. 3, pages 134 - 138
    - C.C. BAKER ET AL., "Epidemiology of Trauma Deaths", AMERICAN JOURNAL OFSURGERY, (1980), pages 144 - 150
    - R.G. LOBENHOFFER ET AL., "Treatment Results of Patients with Multiple Trauma: An Analysis of 3406 Cases Treated Between 1972 and 1991 at a German Level I Trauma Center", JOURNAL OF TRAUMA, (1995), vol. 38, pages 70 - 77
    - "Pathology of Sepsis, Septic Shock, and Multiple Organ Failure", J. COALSON, New Horizons: Multiple Organ Failure, SOCIETY OF CRITICAL CARE MEDICINE, (1986), pages 27 - 59
    - "Multiple Organ Failure Syndrome", F.B. CERRA, New Horizons: Multiple Organ Failure, SOCIETY OF CRITICAL CARE MEDICINE, (1989), pages 1 - 24
    - R. MULLER-SUUR; C. MULLER-SUUR, "Glomerular filtration and tubular secretion of MAG3 in rat kidney", JOURNAL OF NUCLEAR MEDICINE, (1989), vol. 30, pages 1986 - 1991
    - P.D. DOLLAN; E.L. ALPEN; G.B. THEIL., "A clinical appraisal of the plasma concentration and endogenous clearance of creatinine", AMERICAN JOURNAL OF MEDICINE, (1962), vol. 32, pages 65 - 79
    - "Renal excretion and tubular transport of organic anions and cations", F. ROCH-RAMEL; K. BESSEGHIR; H. MURER, Handbook ofPhysiology, Section 8, Neurological Physiology, OXFORD UNIVERSITY PRESS, (1992), vol. II, pages 2189 - 2262
    - D.L. NOSCO; J.A. BEATY-NOSCO, "Chemistry of technetium radiopharmaceuticals 1: Chemistry behind the development of technetium-99m compounds to determine kidney function", COORDINATION CHEMISTRY REVIEWS, (1999), vol. 184, pages 91 - 123
    - P.L. CHOYKE; H.A. AUSTIN; J.A. FRANK., "Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate", KIDNEY INTERNATIONAL, (1992), vol. 41, pages 1595 - 1598
    - N. LEWIS; R. KERR; C. VAN BUREN, "Comparative evaluation ofurographic contrast media, inulin, and 99mTc-DTPA clearance methods for determination of glomerular filtration rate in clinical transplantation", TRANSPLANTATION, (1989), vol. 48, pages 790 - 796
    - "Tubular Function", W.N. TAUXE, Nuclear Medicine in Clinical Urology and Nephrology, APPLETON CENTURY CROFTS, (1985), pages 77 - 105
    - A.R. FRITZBERG ET AL., "Mercaptoacetylglycylglycyglycine", JOURNAL OFNUCLEAR MEDICINE, (1986), vol. 27, pages 111 - 120
    - G. EKANOYAN; N.W. LEVIN, Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification (K/DOQI), NATIONAL KIDNEY FOUNDATION, (2002), pages 1 - 22
    - OZAKI, H. ET AL., "Sensitization of europium(III) luminescence by DTPA derivatives", CHEMISTRY LETTERS, (2000), pages 312 - 313
    - "Polyionic fluorescent bioconjugates as composition agents for continuous monitoring of renal function", R. RAJAGOPALAN, R. ET AL., Molecular Imaging: Reporters, Dyes, Markers, and Instrumentation, (2000), page 3924
    - "Noninvasive renal function assessment by fluorescence detection", DORSHOW, R.B. ET AL., Biomedical Optical Spectroscopy and Diagnostics, Trends in Optics and Photonics Series 22, OPTICAL SOCIETY OF AMERICA, (1998), pages 54 - 56
    - SHIRAI, K. ET AL., "Synthesis and fluorescent properties of 2,5-diamino-3,6-dicyanopyrazine dyes", DYES AND PIGMENTS, (1998), vol. 39, no. 1, pages 49 - 68
    - KIM, J.H. ET AL., "Self-assembling of aminopyrazine fluorescent dyes and their solid state spectra", DYES AND PIGMENTS, (1998), vol. 39, no. 4, pages 341 - 357
    - Medical Optical Tomography, SPIE, (1993), vol. IS11
    - R.B. DORSHOW ET AL., "Non-Invasive Fluorescence Detection of Hepatic and Renal Function", BULL. AM. PHYS. SOC., (1997), vol. 42, page 681
    - "Monitoring Physiological Function by Detection of Exogenous Fluorescent Contrast Agents", R.B. DORSHOW ET AL., Optical Diagnostics of Biological Fluids IV, (1999), vol. 3599, pages 2 - 8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.